Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial

Bibliographic Details
Main Authors:	D'Urzo, Anthony, Ferguson, Gary T, van Noord, Jan A, Hirata, Kazuto, Martin, Carmen, Horton, Rachael, Lu, Yimeng, Banerji, Donald, Overend, Tim
Format:	Online
Language:	English
Published:	BioMed Central 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266210/

Similar Items

Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
by: D’Urzo, Anthony
Published: (2013)

Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study
by: Kerwin, Edward, et al.
Published: (2012)

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial
by: Beeh, Kai M, et al.
Published: (2012)

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study
by: Chapman, Kenneth R, et al.
Published: (2014)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
by: Buhl, Roland, et al.
Published: (2012)

Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study
by: Vincken, Walter, et al.
Published: (2014)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Published: (2014)

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]
Published: (2015)

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study
by: Wang, Chen, et al.
Published: (2015)

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
by: Buhl, Roland, et al.
Published: (2015)

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review
by: Miravitlles, Marc, et al.
Published: (2016)

Once-daily dosing of gentamicin.
by: Soper, D E
Published: (1998)

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial
by: Nathan, Robert A, et al.
Published: (2012)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock, Ashley, et al.
Published: (2011)

Glowing mushrooms
by: Salim, Sabiha, et al.
Published: (2017)

Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study
by: O’Byrne, Paul M., et al.
Published: (2015)

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
by: D'Urzo AD, et al.
Published: (2018-09-01)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
by: Kapitza, C, et al.
Published: (2013)

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
by: Ferguson, Gary T, et al.
Published: (2014)

The challenge of objective confirmation of asthma diagnosis in primary care
by: Kaicker, Jatin, et al.
Published: (2014)

Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data
by: Bleecker, Eugene R, et al.
Published: (2011)

Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study
by: Church, Alison, et al.
Published: (2014)

Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Lichen Glows in the Moonlight
by: Kinsella, John
Published: (2010)

Glowing with health at IMU
Published: (2011)

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy
by: Stynes, Gillian, et al.
Published: (2015)

Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study
by: Kulich, Károly, et al.
Published: (2015)

Benefits of once-daily therapies in the treatment of hypertension
by: Flack, John M, et al.
Published: (2011)

The use of once-daily dosing of gentamicin in obstetrics and gynecology.
by: Wiesenfeld, H C, et al.
Published: (1998)

Potential benefit of dolutegravir once daily: efficacy and safety
by: Fantauzzi, Alessandra, et al.
Published: (2013)

Update on once-daily zonisamide monotherapy in partial seizures
by: Afra, Pegah, et al.
Published: (2014)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
by: Ciszek, Michał
Published: (2013)

Moral relativism as a disconnect between behavioural and experienced warm glow
by: Ferguson, Eamonn, et al.
Published: (2016)

A novel model-based approach for dose determination of glycopyrronium bromide in COPD
by: Arievich, Helen, et al.
Published: (2012)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
by: Travis, Simon P L, et al.
Published: (2014)

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial
by: Busse, W W, et al.
Published: (2014)

Identification of non-value adding (NVA) activities in precast concrete installation sites to achieve low-carbon installation
by: Wu, Peng, et al.
Published: (2013)

CoNVaQ: a web tool for copy number variation-based association studies
by: Simon Jonas Larsen, et al.
Published: (2018-05-01)

IMU nursing students glow with health
Published: (2010)

The glowing business growth and darkness beneath
by: Krishnaveni, Muthiah
Published: (2011)